Search Results

PRT062607 HCL 10mg 10mg  | Purity Not Available

Adooq Bioscience

PRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.

More Information Supplier Page

PRT062607 HCL 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

PRT2607, also known as PRT062607, P505-15, and BIIB057, is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.

More Information Supplier Page

EPZ-5676 10mg 10mg  | Purity Not Available

Adooq Bioscience

EPZ-5676 is a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity.

More Information Supplier Page

Stattic 50mg 50mg  | Purity Not Available

Adooq Bioscience

Stattic is a small molecule shown to selectively inhibit the activation of the Stat3 transcription factor by blocking phosphorylation and dimerization events.

More Information Supplier Page

Stattic 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Stattic is a small molecule shown to selectively inhibit the activation of the Stat3 transcription factor by blocking phosphorylation and dimerization events.

More Information Supplier Page

GSK-J4 50mg 50mg  | Purity Not Available

Adooq Bioscience

GSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 uM for the inhibition of TNF?? release).

More Information Supplier Page

GSK-J4 25mg 25mg  | Purity Not Available

Adooq Bioscience

GSK J4 is a cell permeable prodrug rapidly hydrolyzed by macrophage esterases to GSK-J1, a potent selective jumonji H3K27 demethylase inhibitor; attenuates lipopolysaccharide (LPS)-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 uM for the inhibition of TNF?? release).

More Information Supplier Page